Neurophet AQUA

by Neurophet  · Based in South Korea → — AI-powered Brain Imaging Analysis for Neurodegenerative Diseases
Neurology Nuclear Medicine Radiology

One-off payment, subscription, pay-per-scan
Regulatory Status Disclosed

Overview

Neurophet AQUA is an artificial intelligence-based software solution designed for the quantitative analysis of brain MRI and PET images. It assists clinicians in the diagnosis, treatment planning, and monitoring of various neurodegenerative diseases, including Alzheimer’s disease, mild cognitive impairment, dementia, and multiple sclerosis. The software automates precise segmentation, volumetric quantification of brain structures and lesions, and detection of specific imaging biomarkers such as white matter hyperintensities, cerebral microbleeds, and edema. By providing objective evaluation, normative comparisons (for both Asian and Western populations), and intuitive analysis reports, Neurophet AQUA aims to streamline workflows, reduce manual tasks, and support informed, patient-specific clinical decision-making.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Fast and precise automatic quantification analysis of brain MRI
  • Precision brain MRI segmentation and volumetric analysis
  • Automated lesion localization and quantification (microbleeds, edema, WMH)
  • Quantitative analysis of MRI and PET images (including SUVR)
  • Comparison with normative reference data (Asian & Western populations)
  • Intuitive analysis reports and visualized graphs
  • Multi-time-point and longitudinal analysis for disease progression
  • Supports monitoring of treatment efficacy and side effects (e.g., ARIA)
  • Integration into standard reading environments (PACS)
  • Analysis of Multiple Sclerosis lesions and structural changes

Use Cases

  • Diagnosis and differential diagnosis of Alzheimer's disease and dementia
  • Monitoring of Alzheimer's disease treatment effects and adverse events (ARIA)
  • Evaluation of neurodegeneration and cognitive impairment
  • Analysis and monitoring of Multiple Sclerosis progression
  • Support for clinical trials and research imaging analysis
  • Predicting prognosis from mild cognitive impairment to dementia

What Physicians Need to Know

Brain MRI/CT Analysis
Neurophet AQUA is an AI-powered brain neurodegeneration imaging analysis software that performs quantitative analysis of brain MRI scans. It automatically segments and analyzes brain volume and the severity of white matter degeneration. The software can segment even small brain areas like the hippocampus and provides accurate volume analysis and quantitative numerical values for each area in a report. It also quantifies FLAIR hyperintensity signals of lesions, such as cerebral edema, and detects lesions in T2*GRE and SWI scans, including microbleeds and superficial siderosis. The software has demonstrated comparable segmentation performance to FreeSurfer in most regions, with significantly faster processing time and better intracranial volume repeatability. It also shows consistent white matter hyperintensity (WMH) segmentation across FLAIR types. Neurophet AQUA AD Plus, an extension of AQUA, performs quantitative analysis of MRI and PET images, enabling automated labeling, visualization, volumetric quantification of brain structures and lesions, as well as standardized uptake value ratio (SUVR) analysis. It identifies and quantifies hypointense lesions associated with cerebral microbleeds and superficial siderosis, and hyperintense lesions linked to brain edema. The software provides normal data for both Asian and Western populations for comparison.
Neurodegenerative Disease Screening
Neurophet AQUA is a medical AI solution for the diagnosis of dementia and other neurodegenerative diseases. It helps detect structural changes in the brain early, such as brain atrophy and white matter hyperintensities (WMHs), which are associated with conditions like Alzheimer's disease and vascular dementia. The software provides quantitative analysis of brain MRI and PET images to identify early signs and determine the stage of Alzheimer's disease. It also offers comprehensive analysis of ATNV (Amyloid, Tau, Neurodegeneration, Vascular) biomarkers for a multifaceted evaluation of Alzheimer's disease. Neurophet AQUA MS, a module integrated into AQUA, is designed to analyze brain images of patients with multiple sclerosis, quantifying lesions and structural changes, including lesion count, volume, and progression.
Triage Prioritization Speed
Neurophet AQUA can segment and analyze brain MRI images in as little as five minutes, significantly improving processing speed compared to traditional methods that can take an hour or several hours. This rapid analysis helps clinicians establish dementia diagnoses and treatment strategies more quickly.
Physician Tip

Neurophet AQUA offers rapid and accurate quantitative analysis of brain MRI and PET images, which can significantly aid in the early diagnosis, staging, and monitoring of neurodegenerative diseases like Alzheimer's and Multiple Sclerosis. The automated segmentation and volumetric analysis, including white matter hyperintensities and microbleeds, can support treatment management and help assess treatment-related side effects. The software's ability to provide normative comparisons and longitudinal analysis can be valuable for tracking disease progression and treatment efficacy.

Neurophet AQUA is designed to integrate into standard reading environments such as PACS. The company is actively discussing with radiology AI solution platform companies to supply its products to the US market.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing One-off payment, subscription, pay-per-scan
DeploymentLocally on dedicated hardware
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Neurology, Nuclear Medicine, Radiology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2024-10-25K242215 510(k)Neurophet AQUA

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Neurophet AQUA

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Neurophet AQUA.

View all on YouTube

Frequently Asked Questions

Neurophet AQUA is an AI-powered software designed for quantitative analysis of brain MRI scans. It helps physicians diagnose and manage neurodegenerative diseases like Alzheimer's disease and vascular dementia by segmenting and analyzing brain images to assess brain atrophy and white matter hyperintensities (WMHs). The software provides customized analysis reports and can segment brain images in approximately five minutes, regardless of race, age, or gender.
Neurophet AQUA has received U.S. FDA 510(k) clearance, indicating its compliance with regulatory standards for medical devices. It is intended for use as a support tool for clinicians in assessing structural MRIs, and the results must be reviewed by a trained physician. While the company's website does not explicitly detail HIPAA compliance for AQUA, other brain imaging data solutions emphasize HIPAA-compliant secure cloud-based systems for patient data.
Several other FDA-cleared alternatives exist for brain MRI volumetrics, including NeuroQuant from Cortechs.ai, icometrix icobrain (now GE HealthCare), Quantib ND, Combinostics cNeuro, and Neuroreader. Neurophet AQUA has been shown to have comparable performance to established tools like FreeSurfer in terms of segmentation accuracy and reliability, but with significantly faster processing times.
While Neurophet AQUA offers rapid and reliable segmentation, it is a diagnostic assistant software and its results must be reviewed by a trained physician. The software provides morphometric measurements based on T1 MRI series and can use T2 FLAIR MR series for improved identification of some brain abnormalities. It's important to note that different brain volumetrics products may produce varying numerical results, so a fresh baseline may be needed if switching between tools for long-term patient follow-up.
Neurophet AQUA is designed to integrate into standard reading environments like PACS (Picture Archiving and Communication Systems). It accepts DICOM input and produces morphometric reports that can be displayed on PACS. The software's high throughput capability makes it suitable for routine patient care.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

More in the Neurophet AQUA line

Neurophet AQUA (this page) Neurophet AQUA AD Plus

More from Neurophet

Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-10 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.